Rezolute RZLT
NASDAQ RZLT
$4.16 +0.02 (+0.48%)
As of: Oct 1, 2026 · 10:14 AM EDT

Rezolute (RZLT) Total Non-Current Liabilities (2011 - 2026)

Updated

Rezolute (RZLT) recorded Total Non-Current Liabilities of $11.69 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 9.3% from $12.9 million a year earlier but up 43.6% from the prior quarter.

Analysis

Rezolute (RZLT) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends

Starting with fiscal Q4 2014, Rezolute's Total Non-Current Liabilities history includes 46 quarters.

  • Annual Total Non-Current Liabilities has a five-year compound annual growth rate of -6.2% (FY2021 to FY2026).
  • Across earlier fiscal years, Total Non-Current Liabilities came in at $12.9 million in FY2025 (+14.5%), $11.27 million in FY2024 (+57.9%), $7.14 million in FY2023 (+180.8%) and $2.54 million in FY2022 (-84.2%).
  • Quarterly Total Non-Current Liabilities has ranged from $2.48 million in fiscal Q1 2023 to $20.76 million in fiscal Q2 2022 over the past five years.
  • On a year-over-year basis, Total Non-Current Liabilities has declined for three consecutive quarters, with an average decline of 3.5% over the last eight quarters.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 263.6% in fiscal Q1 2024, against a decline of 85.3% in fiscal Q1 2023 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $8.14 million (Q3 2026), $10.15 million (Q2 2026) and $11.01 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Rezolute 399.12 Mn 399.12 Mn - 11.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.69 Mn
Mar 31, 2026 8.14 Mn
Dec 31, 2025 10.15 Mn
Sep 30, 2025 11.01 Mn
Jun 30, 2025 12.90 Mn
Mar 31, 2025 11.69 Mn
Dec 31, 2024 11.94 Mn
Sep 30, 2024 9.49 Mn
Jun 30, 2024 11.27 Mn
Mar 31, 2024 16.42 Mn
Dec 31, 2023 9.98 Mn
Sep 30, 2023 9.01 Mn
Jun 30, 2023 7.14 Mn
Mar 31, 2023 6.44 Mn
Dec 31, 2022 8.51 Mn
Sep 30, 2022 2.48 Mn
Jun 30, 2022 2.54 Mn
Mar 31, 2022 17.27 Mn
Dec 31, 2021 20.76 Mn
Sep 30, 2021 16.83 Mn
API Access

Rezolute Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RZLT&period=max&api_key=YOUR_API_KEY